Top ten pharma companies in 2020
The global pharmaceutical industry is expected to witness positive growth as the top pharma companies are at forefront of the…
Latest Analysis
-
4 weeks
-
4 weeks
-
2 months
-
2 months
-
4 weeks
-
4 weeks
-
2 months
-
2 months
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Drug development is extremely challenging no matter the condition – nine in ten drugs fail in clinical trials. However, this…
Latest News
View More
Sanofi and Regeneron report eosinophilic esophagiti trial data
Sanofi and Regeneron Pharmaceuticals have reported additional positive results from Part A of a Phase III trial evaluating Dupixent (dupilumab) in patients with eosinophilic esophagitis…
AstraZeneca’s Farxiga prolongs survival in chronic kidney disease trial
AstraZeneca has reported positive data from a subgroup analysis from Phase III DAPA-CKD trial of Farxiga (dapagliflozin) in patients with chronic kidney disease (CKD). The…
Israel to initiate human trials of potential Covid-19 vaccine
The Israel Institute for Biological Research (IIBR) has obtained regulatory approval to initiate human clinical trials for its Covid-19 vaccine…
Lilly and Boehringer report positive outcomes in heart failure trial
Eli Lilly and Boehringer Ingelheim have reported that new exploratory sub-analysis data from the EMPEROR-Reduced Phase III trial showed Jardiance…
Dicerna’s nedosiran achieves urinary oxalate normalisation in PH trial
Dicerna Pharmaceuticals has reported positive interim data from its ongoing PHYOX3 trial of investigational drug candidate, nedosiran, for the treatment of…
Goldfinch Bio reports positive data from GFB-887 trial
Goldfinch Bio has reported positive results from its Phase I clinical trial of GFB-887, a highly potent and selective inhibitor…
Latest Content
View More
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race
On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
WAKIX (pitolisant) for the Treatment of Cataplexy with Narcolepsy
WAKIX® (pitolisant) is the first and only non-scheduled medication indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS)…
Real Time Cargo Intelligence to Increase Distribution Quality and Security
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…